全文获取类型
收费全文 | 4271篇 |
免费 | 160篇 |
国内免费 | 38篇 |
专业分类
耳鼻咽喉 | 89篇 |
儿科学 | 64篇 |
妇产科学 | 73篇 |
基础医学 | 509篇 |
口腔科学 | 72篇 |
临床医学 | 291篇 |
内科学 | 1439篇 |
皮肤病学 | 31篇 |
神经病学 | 314篇 |
特种医学 | 80篇 |
外科学 | 736篇 |
综合类 | 9篇 |
预防医学 | 111篇 |
眼科学 | 60篇 |
药学 | 281篇 |
中国医学 | 4篇 |
肿瘤学 | 306篇 |
出版年
2023年 | 31篇 |
2022年 | 67篇 |
2021年 | 141篇 |
2020年 | 81篇 |
2019年 | 102篇 |
2018年 | 131篇 |
2017年 | 86篇 |
2016年 | 95篇 |
2015年 | 91篇 |
2014年 | 137篇 |
2013年 | 158篇 |
2012年 | 302篇 |
2011年 | 275篇 |
2010年 | 174篇 |
2009年 | 170篇 |
2008年 | 255篇 |
2007年 | 284篇 |
2006年 | 282篇 |
2005年 | 289篇 |
2004年 | 256篇 |
2003年 | 240篇 |
2002年 | 211篇 |
2001年 | 37篇 |
2000年 | 46篇 |
1999年 | 44篇 |
1998年 | 37篇 |
1997年 | 22篇 |
1996年 | 28篇 |
1995年 | 14篇 |
1994年 | 26篇 |
1993年 | 16篇 |
1992年 | 29篇 |
1991年 | 13篇 |
1990年 | 14篇 |
1989年 | 15篇 |
1988年 | 19篇 |
1987年 | 11篇 |
1986年 | 20篇 |
1985年 | 20篇 |
1984年 | 18篇 |
1983年 | 22篇 |
1982年 | 13篇 |
1981年 | 12篇 |
1979年 | 15篇 |
1978年 | 14篇 |
1977年 | 16篇 |
1976年 | 11篇 |
1975年 | 10篇 |
1974年 | 13篇 |
1973年 | 10篇 |
排序方式: 共有4469条查询结果,搜索用时 31 毫秒
101.
102.
103.
Samir Abdurahman Babilonia Barqasho Piotr Nowak Do Duy Cuong Wondwossen Amogne Mattias Larsson Lars Lindquist Gaetano Marrone Anders Snnerborg 《Journal of the International AIDS Society》2014,17(1)
Introduction
The role of microbial translocation (MT) in HIV patients living with HIV from low- and middle-income countries (LMICs) is not fully known. The aim of this study is to investigate and compare the patterns of MT in patients from Vietnam, Ethiopia and Sweden.Methods
Cross-sectional samples were obtained from treatment-naïve patients living with HIV-1 and healthy controls from Vietnam (n=83; n=46), Ethiopia (n=9492; n=50) and Sweden (n=51; n=19). Longitudinal samples were obtained from a subset of the Vietnamese (n=24) in whom antiretroviral therapy (ART) and tuberculostatics were given. Plasma lipopolysaccharide (LPS), sCD14 and anti-flagellin IgG were determined by the endpoint chromogenic Limulus Amebocyte Assay and enzyme-linked immunosorbent assay.Results
All three biomarkers were significantly increased in patients living with HIV-1 from all countries as compared to controls. No differences were found between males and females. Vietnamese and Ethiopian patients had significantly higher levels of anti-flagellin IgG and LPS, as compared to Swedes. ART reduced these levels for the Vietnamese. Vietnamese patients given tuberculostatics at initiation of ART had significantly lower levels of anti-flagellin IgG and higher sCD14. The biomarkers were lower in Vietnamese who did not develop opportunistic infection.Conclusions
Higher MT is common in patients living with HIV compared to healthy individuals, and in patients from LMICs compared to patients from a high-income country. Treatment with tuberculostatics decreased MT while higher levels of MT are associated with a poorer clinical outcome. 相似文献104.
105.
106.
107.
108.
Franco M. Buonaguro Maria Lina Tornesello Elke Beth-Giraldo Angelo Hatzakis Nancy Mueller Robert Downing Bennon Biryamwaho Silvester D. R. Sempala Gaetano Giraldo 《International journal of cancer. Journal international du cancer》1996,65(1):25-28
The identification of Kaposi's sarcoma (KS) clusters in subequatorial Africa (endemic KS, AKS) and the high frequency of KS in sexually transmitted AIDS (epidemic KS, EKS), have previously suggested a role for infectious agents in the etiopathogenesis of KS. The recent identification of herpesvirus (HHV)-like DNA sequences in one case of EKS and their detection in >90% of all tested EKS, prompted us to determine the prevalence of these viral sequences in all types of KS, such as AKS, EKS, classic KS (CKS) and iatrogenic KS (IKS). The presence of herpesvirus (HHV)-like DNA sequences has been examined in 61 KS skin tumors obtained from Greece, Italy, USA, Uganda and Kenya. All KS types (100%) were positive by polymerase chain reaction (PCR) and Southern-blot analysis, while 5 out of 6 (83%) and 4 out of 7 (57%) uninvolved autologous skin biopsies from AKS and CKS patients, respectively, were positive for HHV-like sequences. All samples from non-KS patients were negative, i.e. 17 human biopsies from healthy individuals or patients affected by other pathologies, 5 human cell lines and 15 peripheral blood mononuclear cells (PBMC) from HIV-positive subjects. These results suggest that HHV-like sequences play a major role in the pathogenesis of this neoplasm. © 1996 Wiley-Liss, Inc. 相似文献
109.
Caterina Carbonara Lucia Longa Enrico Grosso Gianna Mazzucco Carla Borrone Maria Luisa Garr Massimo Brisigotti Giorgio Filippi Aldo Scabar Aldo Giannotti Piero Falzoni Guido Monga Gianni Garini Marzio Gabrielli Peter Riegler Cesare Danesino Martino Ruggieri Gaetano Magro Nicola Migone 《Genes, chromosomes & cancer》1996,15(1):18-25
To investigate the molecular mechanisms of tuberous sclerosis (TSC) histopathologic lesions, we have tested for loss of heterozygosity the two TSC loci (TSC1 and TSC2) and seven tumor suppressor gene-containing regions (TP53, NF1, NF2, BRCA1, APC, VHL, and MLM) in 20 hamartomas from 18 TSC patients. Overall, eight angiomyolipomas, eight giant cell astrocytomas, one cortical tuber, and three rhabdomyomas were analyzed. Loss of heterozygosity at either TSC locus was found in a large fraction of the informative patients, both sporadic (7/14) and familial (1/4). Interestingly, a statistically significant preponderance of loss of heterozygosity at TSC2 was observed in the sporadic group (P < 0.01). Among the possible explanations considered, the bias in the selection for TSC patients with the most severe organ impairment seems particularly appealing. According to this view, a TSC2 defect might confer a greater risk for early kidney failure or, possibly, a more rapid growth of a giant cell astrocytoma. None of the seven antioncogenes tested showed loss of heterozygosity, indicating that the loss of either TSC gene product may be sufficient to promote hamartomatous cell growth. Finally, the observation of loss of heterozygosity at different markers in an astrocytoma and in an angiomyolipoma from the same patient might suggest the multifocal origin of the second-hit mutation. Genes Chromosom Cancer 15:18–25 (1996). © 1996 Wiley-Liss, Inc. 相似文献
110.